These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26179060)

  • 21. Induced pluripotent stem cells: from derivation to application in biochemical and biomedical research.
    Novosadova EV; Grivennikov IA
    Biochemistry (Mosc); 2014 Dec; 79(13):1425-41. PubMed ID: 25749158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of iPS cells and of cancer stem cells: the stem cell or reprogramming hypothesis of cancer?
    Trosko JE
    Anat Rec (Hoboken); 2014 Jan; 297(1):161-73. PubMed ID: 24293264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 connects tumorigenesis and reprogramming to pluripotency.
    Tapia N; Schöler HR
    J Exp Med; 2010 Sep; 207(10):2045-8. PubMed ID: 20876313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of induced pluripotent stem cells from neonatal mouse cochlear cells.
    Du D; Lou X
    Differentiation; 2014; 87(3-4):127-33. PubMed ID: 24582575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic reprogramming in cancer.
    Suvà ML; Riggi N; Bernstein BE
    Science; 2013 Mar; 339(6127):1567-70. PubMed ID: 23539597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reprogramming in origin and development of leukemia stem/progenitor cells].
    Wu KF; Ma XT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1123-6. PubMed ID: 19840434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming of human somatic cells by bacteria.
    Ito N; Ohta K
    Dev Growth Differ; 2015 May; 57(4):305-12. PubMed ID: 25866152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cells at nanoscale.
    Zeuschner D; Mildner K; Zaehres H; Schöler HR
    Stem Cells Dev; 2010 May; 19(5):615-20. PubMed ID: 19527182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of reprogramming technology for cancer research].
    Yagi M; Semi K; Yamada Y
    Nihon Rinsho; 2015 May; 73(5):751-5. PubMed ID: 25985626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.